Rabeprazole

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug – in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion. It is grouped under the following drug class(es): Proton Pump Inhibitors. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Habeprazole, pariprazole and Eraloc. Its PubChem CID is 5029.

CAS No 117976-89-3
Molecular Formula C18H21N3O3S
Molecular Weight 359.4 g/mol
Synonyms 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole

Frequently Asked Questions